Newsletter Tool

To view this email as a web page, click here

Editor's Note: Fierce COVID-19 Update will not publish on Monday in observance of the Memorial Day holiday, but we’ll be back in your inbox on Tuesday, June 1.

Today's Rundown

J&J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses
More than just a step-tracker, smartwatches can predict blood test results and infections, study finds
Working remotely helped FDA's CDER shape a new and improved workforce, director says. What now?
UPDATED Coronavirus tracker: Most unvaccinated people say new CDC mask guidelines aren't enough of an incentive
COVID-19 tracker: J&J shot authorized in UK, Mexico; China's Sinopharm releases long-awaited vaccine data
J.D. Power: Telehealth use boosts members' satisfaction with health plans
EFFECTOR Therapeutics bugs out of an IPO, taking the SPAC path with Locust Walk

Featured Story

J&J homes in on manufacturing restart at Emergent plant behind 15M discarded COVID-19 doses

By Fraiser Kansteiner

With production on pause and millions of COVID-19 vaccine doses in limbo, Johnson & Johnson has been hustling to right the ship at CDMO Emergent BioSolutions' troubled Baltimore manufacturing facility. Now, it looks like relief is in sight.

More than just a step-tracker, smartwatches can predict blood test results and infections, study finds

By Conor Hale

The smartwatch on your wrist already reminds you to get more steps in throughout the day, alerts you to new emails and even takes regular pulse readings—but its insights aren’t skin-deep.

Working remotely helped FDA's CDER shape a new and improved workforce, director says. What now?

By Kevin Dunleavy

The pandemic's work-from-home ethos helped the FDA's Center for Drug Evaluation and Research retain talented employees and attract new ones, forcing the organization to reimagine its future, according to director Patrizia Cavazzoni.

UPDATED Coronavirus tracker: Most unvaccinated people say new CDC mask guidelines aren't enough of an incentive

By Healthcare Staff

Follow along with the latest COVID-19 news straight from the Fierce Healthcare team.

COVID-19 tracker: J&J shot authorized in UK, Mexico; China's Sinopharm releases long-awaited vaccine data

By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner

Johnson & Johnson is nearing a deal with the FDA to begin producing shots at Emergent's troubled plant in Baltimore. Meanwhile, the U.K. and Mexico authorized the drugmaker's single-shot vaccine. China's Sinopharm released long-awaited data on its vaccines. And more headlines.

J.D. Power: Telehealth use boosts members' satisfaction with health plans

By Paige Minemyer

Increased telehealth use under the pandemic is encouraging members to engage more with their health plans, according to a new report from J.D. Power.

EFFECTOR Therapeutics bugs out of an IPO, taking the SPAC path with Locust Walk

By Kyle LaHucik

EFFECTOR Therapeutics thinks it can be effective in clinical trial advancement following SPAC merger with Locust Walk

COVID-19 Tracker